Prof. Muhamma El-Taha

Department of Matheamtics and Statistics

University of Southern Maine, USA

Email: eltaha@usm.maine.edu

Qualifications

1987 Ph.D., Operation Research, North Carolina State University, USA

1980 M.S., Statistics, American University of Beirut, Lebanon

1978 B.S., Mathematic, Haigazian College, Beirut, Lebanon

Publications (Selected)

1. Anandarajah AP, Greenberg J, El-Taha M, Peng C, Reed G, Greenberg J, Ritchlin CT.The relationship between erosions and osteoporosis in patients with psoriatic arthritis. Arthritis and Rheumatism. Annals of rheumatic diseases 2008; 67:101.
2. Anandarajah AP, Greenberg J, El-Taha M, Reed G, Peng C, Ritchlin CT. The relationship between erosions and osteoporosis in patients with psoriatic arthritis. Arthritis and Rheumatism 2008;58(9):S366-S367.
3. Fisher MC, El-Taha M, Kremer JM, Peng C, Greenberg J. Smoking cessation and improvement of RA disease activity. Arthritis and Rheumatism 2008;58(9):S610-S610.
4. Anandarajah AP, Greenberg J, El-Taha M, Reed G, Peng C, Ritchlin CT. The relationship between erosions and osteoporosis in patients with psoriatic arthritis. Arthritis and Rheumatism 2008;58(9):S366-S367.
5. Dabbous O, Kremer J, Rambharose J, El-Taha M, Reed G, Tang B, et al. Infliximab,etanercept, and adalimumab switchinu in patients with rheumatoid arthritis in the consortium of rheumatology researchers of North America (Corrona) database. Annals of the Rheumatic Diseases 2007;66:167-167.
6. Dabbous O, Kremer J, El-Taha M, Reed G, Tang B, Thompson H, et al. Socioeconomic status as a determinant of Anti-TNF alpha therapy for rheumatoid arthritis patients:CORRONA database. Arthritis and Rheumatism 2006;54(9):S61-S62.
7. Dabbous O, Kremer J, El-Taha M, Reed G, Tang B, Arjunji R, et al. Infliximab, etanercept and adalimumab switching in patients with rheumatoid arthritis in the consortium of rheumatology researchers of North America (CORRONA) database. Arthritis and Rheumatism 2006;54(9):S705-S705.
8. Dabbous O, Kremer J, El-Taha M, Reed G, Tang B, Thompson H, et al. Socioeconomic status as a determinant of Anti-TNF alpha therapy for rheumatoid arthritis patients:CORRONA database. Arthritis and Rheumatism 2006;54(9):S61-S62.